Emergency Medicine Doctors in La Grange, TX Accepting Medicare

3 Emergency Medicine doctors found. Showing 1 - 3

Dr. Richard Hartin Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: One St. Mark's Place, St. Mark's Hospital, La Grange, TX 78945 Phone: 979-242-2333    Fax: 979-242-5171

John Warren Edwards, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Saint Marks Pl, La Grange, TX 78945 Phone: 979-242-2200

Allyson Borgstedte, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Saint Marks Pl, La Grange, TX 78945 Phone: 904-805-1300    Fax: 904-805-1302

News Archive

FDA approves human embryonic stem cells clinical trial for spinal cord injury treatment

Emerging Healthcare Solutions, Inc.: Last week, the US Food and Drug Administration gave their highly-anticipated approval for the first clinical trial using human embryonic stem cells (hESCs), which are the type of cells that can develop into all tissues of the body. Geron Corporation of Menlo Park, California, received the green light from the US FDA to use cells derived from hESCs to treat people with acute spinal cord injuries. Ten people will receive injections into the injury site of hESC-derived oligodendrocyte progenitor cells, which stimulate the growth of new and severed nerves and recoat damaged nerves with myelin. The hope is that the injections will help people recover function lost through injury, as seen in rodent studies in 2005.

FDA approves RYTARY for Parkinson's disease treatment

Impax Pharmaceuticals, a division of Impax Laboratories, Inc., today announced that the U.S. Food and Drug Administration approved RYTARY, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication and / or manganese intoxication.

New data from Zafgen's ZGN-433 Phase 1b study on obesity presented at ADA 2011

Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.

New CDC report describes COVID-19 in NYC in early spring

The Centres for Disease Control and Prevention (CDC), in its Morbidity and Mortality Weekly Report (MMWR), has published an update on the outbreak in New York City. The report is titled, "COVID-19 Outbreak — New York City, February 29–June 1, 2020".

Nude activists enter House Speaker's office to protest potential AIDS spending cuts

"At least seven nude protesters stormed House Speaker John Boehner's (R-Ohio) office in the Longworth House Office Building on Tuesday, according to reports from Sahil Kapur of Talking Points Memo and others who were there," the Huffington Post reports.

Read more Medical News

› Verified 5 days ago